vialroom

#cagrilintide 2026-04-14

Tuesday46 messages7 participantstimes are UTC
Highlights from this day
  • alt_ast_ali — stopped for 20 months and the fullness went within a fortnight of the last dose 18:25
  • alt_ast_ali — for the archive you cannot tell which of the two is doing what in a combination and i stopped pretending i could 18:41
  • taipei_tare — sorry to jump in held at 5 for 4 months on monotherapy before i touched it again, i have it written down somewhere 18:56
  • batch_bandit — for the archive REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work, i have it written down somewhere 19:49
  • monoisotopic — i titrated over twice as many weeks as i did on semaglutide and that was right for me 21:52
CC

went slower because the first step gave me two rough days and i took that as information

AA

stopped for 20 months and the fullness went within a fortnight of the last dose

🙏12👀16📉1
AA

monotherapy was underwhelming for me and i say that as someone who wanted it to work

the fullness effect hasnt faded over 15 months, unlike my semaglutide appetite curve

AA

the reason nausea reads differently is timing, mine arrived on the second day rather than the first

for the archive you cannot tell which of the two is doing what in a combination and i stopped pretending i could

⚠️14❤️4

anyone dosing this on a different day to their tirzepatide

TT

sorry to jump in held at 5 for 4 months on monotherapy before i touched it again, i have it written down somewhere

📈16

combination for me

TT

update on the earlier thing its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

is the nausea profile genuinely different or am i imagining it

i was sceptical about monotherapy and after 23 months im still sceptical, just less so

Cited study
Efficacy and Safety of Cagrilintide in Adults with Overweight or Obesity — Phase 2
The Lancet · 2021
Cagrilintide monotherapy, dose ranging. The combination trials came later.

is the weekly schedule the same here

QH

combination GI was worse than either alone for me, which is not what i had read anywhere

CC

two PeptideMeter results on the same JEEP lot came back 98.6 and 99.4, closer than i expected

underwhelming honestly

👀6💀1😂17

amylin analogue, so its not a GLP-1 at all right

noticed something around week 6 on monotherapy, well after i had given up expecting to

lot-log.csv
605 rows · not retained in the public archive

added it to an existing tirzepatide dose rather than starting both, which made attribution possible

FF

the nausea felt different rather than less, more fullness and less of the queasy wave

BB

for the archive REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work, i have it written down somewhere

🔥18🤝4📈13

how many weeks before you noticed anything on monotherapy

⚠️4🧊5🎉1
QH

amylin is about slowed gastric emptying and satiety signalling, thats the short version and im no pharmacologist

has REDEFINE reported or are people quoting earlier work

🙏6🧪2🧊1

is anyone running this on its own or is it all CagriSema in here

lost 17lb over 23 months on the combination and i genuinely cannot apportion it

FF

how do people separate which of the two is doing what in a combination

FF

i keep the two on separate days so if something goes wrong i have a chance of knowing which
held at 2.4 for 5 months on monotherapy before i touched it again

dropped the GLP-1 and stayed on this alone for 26 months, appetite held but weight barely moved
the fullness effect hasnt faded over 13 months, unlike my semaglutide appetite curve

MO

i titrated over twice as many weeks as i did on semaglutide and that was right for me

fridge-thermometer.png
800 × 800 · 470 KB · not retained in the public archive
❤️9📈6🧪15

is the slower titration because of nausea or something else

[edited]